Mannan Oligosaccharide Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Mannan oligosaccharides belong to the broader functional carbohydrate and prebiotic segment of the specialty food ingredients market. While the broader global oligosaccharide market, spanning fructo-, galacto-, isomalto-, and other variants, was estimated around $2.0 billion in 2024, MOS occupies a distinct position anchored in animal nutrition applications, particularly aquaculture and swine feed. The MOS segment's individual trajectory of reaching $1.284 billion in 2026 reflects its increasing adoption as a cost-effective, naturally derived alternative to inorganic feed additives.

• •MOS represents a specialized sub-segment within the $2.0+ billion global oligosaccharide market, differentiated by its yeast and plant-derived origins
• •The animal nutrition channel accounts for the majority of current MOS demand, with food-grade and nutraceutical applications emerging as the fastest-growing sub-sector at projected annual growth rates exceeding 12%
• •Adjacent oligosaccharide categories, including human milk oligosaccharides (~$442M in 2026), fructo-oligosaccharides (~$4.05B in 2026), and isomalto-oligosaccharides (~$75M in 2024), provide useful comparators for market sizing

The primary catalyst for MOS market expansion is the global livestock and aquaculture sector's accelerating shift away from antibiotic growth promoters, driven by regulatory mandates across the European Union, Southeast Asia, and parts of North America. MOS functions as a prebiotic that competitively excludes pathogenic bacteria from the gut microbiome of farmed animals, improving feed conversion ratios and reducing mortality, outcomes directly relevant to producers facing margin pressure. A secondary growth engine is the human nutrition and functional food segment, where consumer demand for gut health ingredients has prompted food and beverage manufacturers to incorporate MOS into fortified products.

• •Stringent regulatory bans on sub-therapeutic antibiotic use in animal feed across the EU, China, and the US have created a large, validated addressable market for MOS as a scientifically documented substitute
• •Rising global per capita protein consumption, particularly from farmed fish and shrimp, amplifies demand for cost-efficient health-promoting feed additives that improve yield outcomes
• •Human nutrition applications are expanding, with food-grade MOS projected to grow at a significantly higher rate (circa 12.9% annually through 2033) than the broader animal-grade market, driven by prebiotic product launches

The MOS market is segmented by application into animal nutrition (aquaculture, swine, poultry, and ruminant feed) and human nutrition (functional foods, dietary supplements, infant formula, and beverages). Animal nutrition dominates current volume, while human nutrition drives value growth due to higher pricing tiers and stricter purity requirements. Regionally, North America and Europe represent mature markets with established regulatory frameworks supporting MOS adoption, whereas Asia-Pacific, led by China's extensive aquaculture and feed production infrastructure, is the largest and fastest-growing regional market.

• •Asia-Pacific commands the largest regional share, underpinned by China's dominant position in global aquaculture output and a highly developed commercial feed manufacturing sector
• •North America and Europe collectively represent significant mature markets characterized by stringent regulatory approval processes that validate product quality claims
• •Food-grade MOS, requiring higher purification standards and regulatory compliance than feed-grade variants, is forecast to outpace overall market growth through 2033

Who are the notable companies in the industry?

The competitive landscape of the global MOS market is moderately consolidated, featuring a tiered supplier structure that spans vertically integrated ingredient conglomerates such as Cargill and Lallemand, mid-tier specialty carbohydrate manufacturers like Orffa and Fubon, and smaller regional processors including Biofeed and Sensient Technologies. Leading producers maintain a competitive edge through upstream integration of yeast biomass fermentation capacity, the dominant manufacturing route, delivering cost advantages and supply chain security. The technology base relies on autolysis and hydrolysis of *Saccharomyces cerevisiae* cell walls, with enzymatic modification processes enabling tailored mannan polymer chain lengths for specific applications. Yiduoli and Matrix Nutrition have expanded their footprint particularly in Asian markets, capitalizing on regional fermentation infrastructure. Significant production capacity remains concentrated across North America, Western Europe, and China, with growing investment in Southeast Asian processing facilities positioned closer to aquaculture demand centers.

• •The market exhibits moderate consolidation with a handful of large integrated producers controlling fermentation capacity, alongside numerous regional and specialty manufacturers focused on specific application grades
• •Fermentation of yeast biomass (Saccharomyces cerevisiae) via autolysis or enzymatic hydrolysis remains the dominant production technology; emerging extraction methods from plant-based sources such as konjac and copra meal add supply-side diversity
• •Production capacity is geographically concentrated in North America, Europe, and China, with incremental capacity additions underway in Southeast Asia to serve regional aquaculture and feed industries

What are the recent trends and outlook?

The MOS market is positioned for sustained growth through 2033, supported by structurally embedded demand from regulatory-driven antibiotic alternatives in animal feed and a broadening base of human nutrition applications. Key trends include the rapid expansion of food-grade MOS products, increased investment in fermentation capacity and process efficiency, and growing demand for certified organic and non-GMO certified variants. Pricing dynamics face moderate downward pressure as new fermentation capacity enters the market and commodity yeast biomass availability fluctuates, though differentiation through purification technology and application-specific formulation capability supports margin maintenance among leading suppliers.

• •Food-grade MOS is emerging as the highest-value growth segment, with demand propelled by prebiotic ingredient positioning in functional beverages, dairy, and dietary supplements targeting the human gut health market
• •Regulatory divergence across regions, varying tolerances for genetically modified fermentation inputs and organic certification standards, creates opportunities for producers with multi-region compliance capabilities
• •Long-term market expansion is underpinned by structural secular demand from global aquaculture and the persistent need for scientifically validated, non-antibiotic feed performance enhancers